This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.
Valcyte works by preventing the spread of cytomegalovirus (CMV) disease, or slowing the growth of CMV. It is indicated for the treatment of CMV retinitis in adult patients with acquired immunodeficiency syndrome (AIDS), and the prevention of CMV disease in adult and pediatric solid organ transplant patients who are at risk of infection.
In case of any adverse events or safety queries, please contact:
If you have a scientific query related to one of Roche's products, please contact:
M-PK-00001707
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.
Please be aware that you are leaving this website.